Provided by Tiger Fintech (Singapore) Pte. Ltd.

Trevi Therapeutics, Inc.

6.75
+0.46007.31%
Post-market: 6.75-0.0008-0.01%19:52 EDT
Volume:1.92M
Turnover:12.72M
Market Cap:603.22M
PE:-15.21
High:6.78
Open:6.29
Low:6.28
Close:6.29
Loading ...

Trevi Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
Yesterday

Trevi Therapeutics to Report Fourth Quarter and Year End 2024 Financial Results and Provide a Corporate Update on March 18, 2025

PR Newswire
·
12 Mar

TRVI Stock Soars on Meeting Primary Goal in Chronic Cough Study

Zacks
·
11 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Trevi Therapeutics (TRVI)

TIPRANKS
·
11 Mar

HC Wainwright Adjusts Trevi Therapeutics Price Target to $12.50 From $7.50, Maintains Buy Rating

MT Newswires Live
·
11 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Reuters
·
11 Mar

Leerink Adjusts Price Target on Trevi Therapeutics to $11 From $7, Maintains Outperform Rating

MT Newswires Live
·
10 Mar

Trevi Therapeutics Reveals Positive Data From Mid-Stage Study For Chronic Cough Candidate, Stock Jumps

Benzinga
·
10 Mar

Trevi Therapeutics Inc : Leerink Partners Raises Target Price to $11 From $7

THOMSON REUTERS
·
10 Mar

Trevi Shares Climb On Positive Results for Chronic Cough Treatment

Dow Jones
·
10 Mar

Trevi Therapeutics Shares Jump Over 60% After Cough Therapy Succeeds in Mid-Stage Trial

THOMSON REUTERS
·
10 Mar

Analysts’ Top Healthcare Picks: Trevi Therapeutics (TRVI), Oncolytics Biotech (ONCY)

TIPRANKS
·
10 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Primo Brands, Cracker Barrel, Redfin

Reuters
·
10 Mar

Recession Fears Drive Premarket Losses for US Equity

MT Newswires Live
·
10 Mar

Top Premarket Gainers

MT Newswires Live
·
10 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Airbnb, Beacon, Redfin

Reuters
·
10 Mar